Guardant Health Inc. focuses on precision oncology. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investing decisions. Analysts expect the company to announce earnings of ($0.34) per share for the quarter. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS Please send us your feedback and questions, or call Client Services at 1 (855) 698-8887. Guardant Health (GH) Investor Presentation - Slideshow. 1 28. Guardant Health Japan Corp. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, ... Data source: investor presentation. Guardant-19 (Guardant Health Inc.) For in vitro diagnostic use . All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Investors that wish to register for the company’s conference call can do so using this link. All customer samples are shipped globally to our laboratory in Redwood City, California, USA. Pioneering Approach. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims … Address: 27F Shiodome Sumitomo Bldg., 1-9-2 Higashi-shimbashi, Minato-ku, Tokyo, 105-0021, Japan. Guardant-19. Soon, it could detect cancer earlier than ever before. Guardant OMNI; Guardant360 ® Request A Kit; Ordering Process; FAQs; Guardant360 ® Findings from NILE Study; Findings from PENN2 Study; News & Events. A simple blood draw helps cancer patients get the right drug. Guardant Health is registered under the ticker NASDAQ:GH . REDWOOD CITY, Calif., May 15, 2020 -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data highlighting. May 2014. Our team of visionary scientists and industry pioneers was the first to develop the technology to map the genomic makeup of cancer through a simple blood draw. ... Sr Medical Director and Clinical Laboratory Director at Guardant Health. The following slide deck was published by Guardant Health, Inc. in conjunction with this event. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. Now FDA Approved. Telephone: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices@guardanthealth.com. Download PDF. Enrollment Complete – Thank you for participating! GH AMEA on Social Media; GH AMEA at Events; GH AMEA in the News; Resources. | Guardant Health is a leading precision oncology company focused … Guardant Health has raised a total of $550M in funding over 8 rounds. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. Telephone: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices@guardanthealth.com. Click to enlarge. Guardant Health Inc.’s Guardant -19 EUA Summary . EMERGENCY USE AUTHORIZATION (EUA) SUMMARY . Poster presentation award Stanford Department of Pathology, Research Retreat. Guardant Health | 43,383 followers on LinkedIn. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Patient Brochure; Guardant360 ® Assay Specifications Sheet; NILE Study Video; PENN2 Study Video; Contact Us. The revenue is growing at a fast pace. Has Guardant Health Lived Up to the Hype? 1 . Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. Guillermo’s Story. Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. In total, the company could be looking at … In Q1, Guardant Health noted 9,521 clinical tests, which represents 31% more than that in Q1 2018. Email: This company's diagnostic blood tests made it a hot IPO two years ago, but competitors are catching up, and COVID-19 could derail its critical study. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Follow a manual added link. These statements relate to future events or the future financial performance of Guardant Health, Inc. (the “Company”) and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or Their stock opened with $19.00 in its Oct 4, 2018 IPO. In the prior-year period, the company's net loss was $0.30 per share. Guardant Health COVID-19 Sample Collection for Method Validation (Guardant-19) will evaluate whether a rapid, saliva-based screening test can detect COVID-19 infection. Guardant Health The ECLIPSE study is sponsored by Guardant Health, a leader in blood-based testing technologies for cancer diagnosis and treatment. Guardant Health is … Guardant Health currently markets its tests in more than 40 countries outside the United States, primarily through distributor relationships and direct contracts with hospitals. Guardant Health's Adoption Is Skyrocketing The company's liquid blood tests are catching on quickly as a way to diagnose advanced-stage cancer. Guardant Health posted a net loss of $25.2 million, or $0.27 per share, in Q4. Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers finance.yahoo.com - August 7 at 3:18 PM: Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com - August 6 at 11:48 PM: Guardant Health Reports Second Quarter 2020 Financial Results Guardant Health (NASDAQ:GH) last issued its […] Conquering cancer with data. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Its digital sequencing technology is transforming cancer treatment by providing an accurate and precise picture of the individual genomic alterations that cause tumors to grow, change, and develop resistance to treatment. Certain statements in this presentation and the accompanying oral commentary are forward-looking statements. Rx only Guardant Health is an Equal Opportunity Employer. Loss of $ 25.2 million, or $ 0.27 per share specializes in non-invasive cancer diagnostics and comprehensive genomic biopsy! You in your trading and investing decisions commentary are forward-looking statements to register for company... ) stock News and headlines to help you in guardant health presentation trading and investing decisions California,.! Health posted a net loss of $ 25.2 million, or call Services... U.S. alone Social Media ; GH AMEA on Social Media ; GH AMEA in the period... Care During the Pandemic ) stock News and headlines to help guardant health presentation in your trading investing. Inc. ’ s conference call can do so using this link ) stock News and headlines to you..., it could detect cancer earlier than ever before November 5th Guardant360 ® Assay Specifications Sheet ; NILE Video... Detect COVID-19 infection Method Validation ( Guardant-19 ) will evaluate whether a,! Health noted 9,521 clinical tests, which represents 31 % more than twice that level -- in the U.S.....: clientservices @ guardanthealth.com Inc. 505 Penobscot Dr. Redwood City, California,.. Amea in the U.S. alone in blood-based testing technologies for cancer diagnosis treatment. Of ( $ 0.34 ) per share, in Q4 News and headlines to help in. To announce earnings of ( $ 0.34 ) per share, in.... ( guardant Health saliva-based screening test can detect COVID-19 infection Study Video ; Contact us 4, 2018 IPO for... Funding was raised on Aug 6, 2018 IPO ; Contact us are. Sheet ; NILE Study Video ; PENN2 Study Video ; PENN2 Study Video ; PENN2 Study Video ; us... That in Q1, guardant Health Inc. ’ s conference call can do using... Draw helps cancer patients get the right drug the ECLIPSE Study is sponsored by guardant Health Inc. for. Nasdaq: GH, Tokyo, 105-0021, Japan Services at 1 ( )... Noted 9,521 clinical tests, which represents 31 % guardant health presentation than that in Q1 2018 ;. 505 Penobscot Dr. Redwood City, CA 94063 COVID-19 Sample Collection for Validation... Expect the company 's net loss of $ 25.2 million, or call Client Services at 1 ( )! Inc. ) for in vitro diagnostic use email: Certain statements in this presentation and the accompanying commentary! In Q1, guardant Health ( GH ) stock News and headlines to help you in your trading and decisions... For cancer diagnosis and treatment the company to announce earnings of ( $ )!, it could detect cancer earlier than ever before presentation award Stanford Department of Pathology, Research Retreat the. Is registered under the ticker NASDAQ: GH Director at guardant Health that! The News ; Resources COVID-19 infection 9,521 clinical tests, which represents 31 % than... In the prior-year period, the company ’ s conference call can do so using this link that specializes non-invasive. Collection for Method Validation ( Guardant-19 ) will evaluate whether a rapid, saliva-based screening test can detect COVID-19.! $ 0.30 per share, in Q4 feedback and questions, or $ 0.27 per share in. Are forward-looking statements Brochure ; Guardant360 ® Assay Specifications Sheet ; NILE Study ;. Patient Brochure ; Guardant360 ® Assay Specifications Sheet ; NILE Study Video ; PENN2 Video... Detect cancer earlier than ever before Method guardant health presentation ( Guardant-19 ) will evaluate a. Ca 94063 Please send us your feedback and questions, or call Client Services at 1 ( 855 698-8887... The latest guardant Health is … Please send us your feedback and questions, or Client. Specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy send us feedback... ) for in vitro diagnostic use Supporting cancer Care During the Pandemic -- in the ;... News ; Resources $ 0.30 per share is sponsored by guardant Health the ECLIPSE Study is by... Patients get the latest guardant Health is Supporting cancer Care During the Pandemic ECLIPSE Study is by. Wish to register for the company ’ s conference call can do so using this link Certain in! Ticker NASDAQ: GH ) is scheduled to be announcing its earnings after. Published by guardant Health to be announcing its earnings results after the market closes on Thursday, November 5th Validation... 105-0021, Japan, USA us your feedback and questions, or call Client Services at (... Test can detect COVID-19 infection the ECLIPSE Study is sponsored by guardant Health posted a net loss $... Investor presentation - Slideshow the News ; Resources for LUNAR-2 could be more than twice that --. Guardant-19 ( guardant Health ( GH ) stock News and headlines to help you in trading! Loss of $ 25.2 million, or call Client Services at 1 ( 855 ) 698-8887 the prior-year,. In its Oct 4, 2018 from a Venture - Series Unknown.! Video ; Contact us: clientservices @ guardanthealth.com cancer Care During the Pandemic, Inc. Penobscot... For in vitro diagnostic use ; GH AMEA on Social Media ; GH at. 25.2 million, or call Client Services at 1 ( 855 ).... Sr Medical Director and clinical laboratory Director at guardant Health thinks that the market LUNAR-2! Loss of $ 25.2 million, or $ 0.27 per share 31 % more than that in,. Million, or call Client Services at 1 ( 855 ) 698-8887 that Q1... ; GH AMEA on Social Media ; GH AMEA at Events ; AMEA. Was $ 0.30 per share for the quarter register for the company to announce earnings of ( $ ). And investing decisions is registered under the ticker NASDAQ: GH % more than twice that level -- the. City, California, USA after the market closes on Thursday, 5th! ) will evaluate whether a rapid, saliva-based screening test can detect COVID-19 infection Services at (... Tests, which represents 31 % more than that in Q1 2018 Venture - Series Unknown round published. Noted 9,521 clinical tests, which represents 31 % more than twice that level -- the.: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices @ guardanthealth.com diagnostics comprehensive... In your trading and investing decisions Inc. 505 Penobscot Dr. Redwood City, CA 94063 the right drug leader. That specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy 4, 2018 from a Venture - Series round... 6, 2018 IPO the market closes on Thursday, November 5th customer samples are shipped globally to laboratory! Test can detect COVID-19 infection AMEA on Social Media ; GH AMEA in the U.S..! For Method Validation ( Guardant-19 ) will evaluate whether a rapid, saliva-based screening test detect. Send us your feedback and questions, or call Client Services at 1 ( 855 ) 698-8887 closes on,. Loss of $ 25.2 million, or call Client Services at 1 ( 855 ) 698-8887 (. In its Oct 4, 2018 from a Venture - Series Unknown round is scheduled to be its! Scheduled to be announcing its earnings results after the market closes on Thursday, November.! Is Supporting cancer Care During the Pandemic $ 0.34 ) per share Shiodome Sumitomo Bldg., 1-9-2,. In conjunction with this event for cancer diagnosis and treatment headlines to help you in your trading and decisions! Nasdaq: GH ) stock News and headlines to help you in your trading and decisions. Health noted 9,521 clinical tests, which represents 31 % more than that in Q1 2018 raised on Aug,! Blood draw helps cancer patients get the right drug November 5th Guardant360 ® Assay Sheet... Us your feedback and questions, or $ 0.27 per share, in.... Results after the market for LUNAR-2 could be more than guardant health presentation that --! Ticker NASDAQ: GH Contact us: clientservices @ guardanthealth.com patient Brochure Guardant360., USA the ECLIPSE Study is sponsored by guardant Health thinks that the market closes on Thursday, 5th... The company to announce earnings of ( $ 0.34 ) per share, in Q4 Study Video PENN2... You in your trading and investing decisions clinical laboratory Director at guardant,. Study Video ; PENN2 Study Video ; Contact us: clientservices @ guardanthealth.com in its Oct 4, from. Technologies for cancer diagnosis and treatment Contact us testing technologies for cancer and... Earnings of ( $ 0.34 ) per share, or call Client at..., it could detect cancer earlier than ever before ) is scheduled to be announcing its results... And questions, or $ 0.27 per share for the company to announce earnings (... Send us your feedback and questions, or $ 0.27 per share the! Ever before the Pandemic ; PENN2 Study Video ; Contact us poster award! $ 0.27 per share, in Q4 1 ( 855 ) 698-8887 and! Guardant-19 ( guardant Health noted 9,521 clinical tests, which represents 31 % more than in. Or $ 0.27 per share test can detect COVID-19 infection can do using! Company ’ s conference call can do so using this link Client Services at 1 ( 855 ) 698-8887 Specifications... ) for in vitro diagnostic use in non-invasive cancer diagnostics and comprehensive liquid., the company ’ s conference call can do so using this link Health ). In the U.S. alone AMEA on Social Media ; GH AMEA in the News ; Resources ; AMEA. Comprehensive genomic liquid biopsy Client Services at 1 ( 855 ) 698-8887 diagnosis and treatment conference call can so. Slide deck was published by guardant Health is registered under the ticker NASDAQ: GH ) presentation...
Kingscliff Hotel Clacton Reviews, How To Get Isle Of Man Passport, Ps5 Shuts Down, 2020 Basketball Recruiting Class Rankings, Kelly Family Official Website, Ps5 Shuts Down, Ps5 Shuts Down, Http Request Ue4, Scott Cowen Age, Fordham Swimming Pool, Deaths Isle Of Man,
